Allogene's monster IPO defies a market rout via bopinion
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Biotech unicorn takes rare, rapid road to IPOAllogene hopes to sell off-the-shelf cancer immunotherapies. But the firm is under a year old and its treatments may take 10 years to reach the market. Going public bucks the trend of startups staying private for longer. Its founders are striking while their reputations are hot.
Read more »
One ugly IPO highlights what's wrong with the whole market via @bopinion
Read more »
US subpoenas Snap Inc. on IPO disclosures, after shareholder lawsuit over InstagramFederal authorities subpoena social media company Snap Inc on IPO disclosures, the company confirms to ABC.
Read more »
Lyft raises IPO price range ahead of Friday IPOLyft raised its expected price range to $70 to $72 per share, according to an amended S-1.
Read more »
Lyft IPO: 5 things to know about the ride-hailing company ahead of its IPOLyft Inc. appears poised to beat rival Uber Technologies Inc. to an initial public offering, and that’s important for a number of reasons.
Read more »
Warren Buffett: I'm not buying the Uber IPO, but I've never bought any IPO everBerkshire Hathaway Chairman and CEO Warren Buffett explains why he passed on Uber's initial public offering.
Read more »
Warren Buffett: I'm not buying the Uber IPO, but I've never bought any IPO“In 54 years, I don’t think Berkshire has ever bought a new issue,” Warren Buffett said.
Read more »